Literature DB >> 8811748

Thrombolysis in acute stroke.

J Bogousslavsky.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8811748      PMCID： PMC2351981          DOI： 10.1136/bmj.313.7058.640

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Thrombolytic therapy for acute ischaemic stroke: promising, perilous, or unproven?

Authors:  P Sandercock
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321

2.  Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group.

Authors:  M Hommel; J P Boissel; C Cornu; F Boutitie; K R Lees; G Besson; D Leys; P Amarenco; M Bogaert
Journal:  Lancet       Date:  1995-01-07       Impact factor: 79.321

3.  Trials of streptokinase in severe acute ischaemic stroke.

Authors:  G A Donnan; S M Davis; B R Chambers; P C Gates; G J Hankey; J J McNeil; D Rosen; E G Stewart-Wynne; R R Tuck
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

Review 4.  Evolving toward effective therapy for acute ischemic stroke.

Authors:  M Fisher; J Bogousslavsky
Journal:  JAMA       Date:  1993-07-21       Impact factor: 56.272

5.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Authors:  W Hacke; M Kaste; C Fieschi; D Toni; E Lesaffre; R von Kummer; G Boysen; E Bluhmki; G Höxter; M H Mahagne
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272
  5 in total
  1 in total

1.  Risk-benefit analysis: from a logical point of view.

Authors:  Georg Spielthenner
Journal:  J Bioeth Inq       Date:  2012-03-21       Impact factor: 1.352
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.